Literature DB >> 25864039

Comprehensive analysis of microRNA expression profile in malignant glioma tissues.

Monika Piwecka1, Katarzyna Rolle1, Agnieszka Belter1, Anna Maria Barciszewska2, Marek Żywicki3, Marcin Michalak4, Stanisław Nowak2, Mirosława Z Naskręt-Barciszewska1, Jan Barciszewski5.   

Abstract

Malignant gliomas represent the most devastating group of brain tumors in adults, among which glioblastoma multiforme (GBM) exhibits the highest malignancy rate. Despite combined modality treatment, GBM recurs and is invariably fatal. A further insight into the molecular background of gliomagenesis is required to improve patient outcomes. The primary aim of this study was to gain broad information on the miRNA expression pattern in malignant gliomas, mainly GBM. We investigated the global miRNA profile of malignant glioma tissues with miRNA microarrays, deep sequencing and meta-analysis. We selected miRNAs that were most frequently deregulated in glioblastoma tissues, as well as in peritumoral areas, in comparison with normal human brain. We identified candidate miRNAs associated with the progression from glioma grade III to glioma grade IV. The meta-analysis of miRNA profiling studies in GBM tissues summarizes the past and recent advances in the investigation of the miRNA signature in GBM versus noncancerous human brain and provides a comprehensive overview. We propose a list of 35 miRNAs whose expression is most frequently deregulated in GBM patients and of 30 miRNA candidates recognized as novel GBM biomarkers.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain tumors; Glioblastoma; Gliomas; Meta-Analysis; miRNA profiling; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25864039      PMCID: PMC5528820          DOI: 10.1016/j.molonc.2015.03.007

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  75 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300.

Authors:  Y Zhou; Y Hu; M Yang; P Jat; K Li; Y Lombardo; D Xiong; R C Coombes; S Raguz; E Yagüe
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

3.  MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.

Authors:  Wen-Bo Li; Min-Wang Ma; Li-Jie Dong; Fei Wang; Lu-Xia Chen; Xiao-Rong Li
Journal:  Cancer Biol Ther       Date:  2011-09-15       Impact factor: 4.742

4.  MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.

Authors:  Lili Jiang; Chuyong Lin; Libing Song; Jueheng Wu; Baixue Chen; Zhe Ying; Lishan Fang; Xiao Yan; Mian He; Jun Li; Mengfeng Li
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

5.  Survey of MicroRNA expression in pediatric brain tumors.

Authors:  Diane K Birks; Valerie N Barton; Andrew M Donson; Michael H Handler; Rajeev Vibhakar; Nicholas K Foreman
Journal:  Pediatr Blood Cancer       Date:  2010-11-03       Impact factor: 3.167

6.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

7.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes.

Authors:  Elodie Lages; Audrey Guttin; Michèle El Atifi; Claire Ramus; Hélène Ipas; Isabelle Dupré; Delphine Rolland; Caroline Salon; Catherine Godfraind; Florence deFraipont; Mehdi Dhobb; Laurent Pelletier; Didier Wion; Emmanuel Gay; François Berger; Jean-Paul Issartel
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma.

Authors:  Manu Setty; Karim Helmy; Aly A Khan; Joachim Silber; Aaron Arvey; Frank Neezen; Phaedra Agius; Jason T Huse; Eric C Holland; Christina S Leslie
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

Review 10.  The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease.

Authors:  E Mogilyansky; I Rigoutsos
Journal:  Cell Death Differ       Date:  2013-12       Impact factor: 15.828

View more
  37 in total

1.  Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.

Authors:  Young-Eun Seo; Hee-Won Suh; Raman Bahal; Alexander Josowitz; Junwei Zhang; Eric Song; Jiajia Cui; Seth Noorbakhsh; Christopher Jackson; Tom Bu; Alexandra Piotrowski-Daspit; Ranjit Bindra; W Mark Saltzman
Journal:  Biomaterials       Date:  2019-02-14       Impact factor: 12.479

Review 2.  MicroRNA as potential biomarkers in Glioblastoma.

Authors:  Zammam Areeb; Stanley S Stylli; Rachel Koldej; David S Ritchie; Tali Siegal; Andrew P Morokoff; Andrew H Kaye; Rodney B Luwor
Journal:  J Neurooncol       Date:  2015-09-21       Impact factor: 4.130

Review 3.  Exosomes as Tools to Suppress Primary Brain Tumor.

Authors:  Mark Katakowski; Michael Chopp
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

Review 4.  Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.

Authors:  Agnieszka Bronisz; Jakub Godlewski; E Antonio Chiocca
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

5.  Comprehensive analysis of microRNA expression profile in malignant glioma tissues.

Authors:  Monika Piwecka; Katarzyna Rolle; Agnieszka Belter; Anna Maria Barciszewska; Marek Żywicki; Marcin Michalak; Stanisław Nowak; Mirosława Z Naskręt-Barciszewska; Jan Barciszewski
Journal:  Mol Oncol       Date:  2015-03-25       Impact factor: 6.603

Review 6.  MicroRNA and extracellular vesicles in glioblastoma: small but powerful.

Authors:  Arun K Rooj; Marco Mineo; Jakub Godlewski
Journal:  Brain Tumor Pathol       Date:  2016-03-11       Impact factor: 3.298

Review 7.  Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.

Authors:  Jean-Michel Lemée; Anne Clavreul; Philippe Menei
Journal:  Neuro Oncol       Date:  2015-07-22       Impact factor: 12.300

8.  Overexpression of microRNA-939-5p Contributes to Cell Proliferation and Associates Poor Prognosis in Glioma.

Authors:  Haitao Zheng; Hui Zhao; Gang Ye
Journal:  Neuromolecular Med       Date:  2021-03-30       Impact factor: 3.843

9.  Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.

Authors:  Xing Wei; Qing-Mei Zhang; Chang Liu; Song Wu; Wei-Xia Nong; Ying-Ying Ge; Li-Na Lin; Feng Li; Xiao-Xun Xie; Bin Luo
Journal:  Curr Med Sci       Date:  2022-06-08

10.  Altered Expression of miR-575 in Glioma is Related to Tumor Cell Proliferation, Migration, and Invasion.

Authors:  Guangxin Wei; Shengjun Li; Pengcheng Wang; Shouxian Wang; Yujing Zhao
Journal:  Neuromolecular Med       Date:  2021-07-16       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.